Steroid treatment for focal brain artery inflammation in children
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether short-term steroids improve recovery for children who recently had a stroke or mini-stroke caused by inflammation of a brain artery. If you qualify, you would receive steroids and follow-up imaging to see if it helps prevent further damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 18 years old (up to your 19th birthday).
- You had a stroke or mini-stroke in the last 4 days (96 hours).
- Your MRI shows swelling or narrowing in one brain artery consistent with FCA.
- You can return for a follow-up MRI about 1 month later.
- You haven't had a prior stroke or another known cause of stroke (except FCA).
- You are not pregnant or breastfeeding, and don't have conditions that prevent steroid use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether high-dose steroids given soon after a stroke can improve outcomes for children. It is aimed at children whose stroke is caused by a one-sided blood-vessel problem seen on brain scans.
This trial tests if giving a steroid (methylprednisolone) directly into the brain artery after successful clot removal improves recovery. It is for people who had a large stroke in the front part of the brain and got the clot out within 24 hours.
This study tests if adding a steroid medication (methylprednisolone) to the standard procedure of removing a large blood clot from the brain can improve recovery for people with a severe ischemic stroke. It is for adults who can have the clot removal procedure and have a large area of brain damage.
This trial tests whether injecting a steroid (methylprednisolone) directly into brain blood vessels after removing a stroke clot helps reduce brain swelling and improve recovery. You would be eligible if you had a large clot stroke in the front part of your brain that was successfully removed within the past 24 hours.
This trial tests if the steroid methylprednisolone helps people who have had a major stroke and also have low infection-fighting white blood cells (lymphocytes). It is for patients who are getting a procedure to remove the clot (thrombectomy) within 24 hours of the stroke.
This study tests whether a steroid called methylprednisolone, given soon after a flow diverter stent is placed, can help reduce inflammation and improve outcomes for people with an unruptured brain aneurysm. It is for patients who are already scheduled for this stent procedure.
Hear when a new Pediatric Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.